Haploidentical bone marrow transplant with posttransplant cyclophosphamide for sickle cell disease: An update

Keyphrases

• Sickle Cell Disease 100%
• Hematopoietic Cell Transplant 100%
• Total Body Irradiation 100%
• Haploidentical 100%
• Post-transplantation Cyclophosphamide (PTCy) 100%
• Haploidentical Bone Marrow Transplant 100%
• Tertiary Care Hospital 50%
• High Dose 50%
• Improved Outcomes 50%
• Graft Rejection 50%
• Red Blood Cell Transfusion 50%
• Thiotepa 50%
• Human Leukocyte Antigen Mismatch 50%
• Unrelated Donor 50%
• Transplant Eligibility 50%
• Multiple Strategies 50%
• Recent Approaches 50%
• Johns Hopkins 50%
• Long-term Potential 50%

Medicine and Dentistry

• Transplantation 100%
• Sickle-Cell Disease 100%
• Bone Marrow Transplantation 100%
• Cyclophosphamide 100%
• Whole Body Radiation 50%
• Hematopoietic Cell 50%
• Drug Megadose 25%
• Human Leukocyte Antigen 25%
• Erythrocyte Transfusion 25%
• Graft Rejection 25%
• Thiotepa 25%

Immunology and Microbiology

• Hematopoietic Cell 100%
• Sickle Cell 100%
• Bone Marrow Transplantation 100%
• Cyclophosphamide 100%
• Drug Megadose 50%
• Hemocyte 50%
• Human Leukocyte Antigen 50%